Comment on Cambridge's Idera plans eventual move out of state after merger with BioCryst

Cambridge's Idera plans eventual move out of state after merger with BioCryst

On Monday, Cambridge-based Idera Pharmaceuticals announced plans to merge with BioCryst Pharmaceuticals, based in Durham, North Carolina, with the resulting company to be based in Exton, Pennsylvania. The combined company – to be renamed upon the merger’s closing – will be headquartered in Exton, with a consolidated research center slated for Birmingham, Alabama.  As part of the all-stock deal, a spokesman for Idera (Nasdaq: IDRA) said Monday that eventually that company's current Cambridge…

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News